Literature DB >> 12829526

A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries.

Anthony Rodgers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829526      PMCID: PMC1126301          DOI: 10.1136/bmj.326.7404.1407

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

1.  Two decades of progress in preventing vascular disease.

Authors:  Salim Yusuf
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

Review 2.  Risk factor thresholds: their existence under scrutiny.

Authors:  M R Law; N J Wald
Journal:  BMJ       Date:  2002-06-29

3.  The world health report 2002 - reducing risks, promoting healthy life.

Authors:  J J Guilbert
Journal:  Educ Health (Abingdon)       Date:  2003-07

4.  Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

Authors:  D Wood; G De Backer; O Faergeman; I Graham; G Mancia; K Pyörälä
Journal:  J Hypertens       Date:  1998-10       Impact factor: 4.844

5.  Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.

Authors:  Christopher J L Murray; Jeremy A Lauer; Raymond C W Hutubessy; Louis Niessen; Niels Tomijima; Anthony Rodgers; Carlene M M Lawes; David B Evans
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

6.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

Authors: 
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

7.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

8.  Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study.

Authors:  Tom Marshall; Andrew Rouse
Journal:  BMJ       Date:  2002-07-27

9.  Management of raised blood pressure in New Zealand: a discussion document.

Authors:  R Jackson; P Barham; J Bills; T Birch; L McLennan; S MacMahon; T Maling
Journal:  BMJ       Date:  1993-07-10

10.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28
  10 in total
  12 in total

1.  "Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.

Authors:  Andrea Messori; Benedetta Santarlasci; Sabrina Trippoli; Monica Vaiani
Journal:  BMJ       Date:  2003-10-04

2.  "Polypill" to fight cardiovascular disease: patients before populations.

Authors:  Peter Trewby; Catherine Trewby
Journal:  BMJ       Date:  2003-10-04

Review 3.  Diseases of comfort: primary cause of death in the 22nd century.

Authors:  Bernard C K Choi; David J Hunter; Walter Tsou; Peter Sainsbury
Journal:  J Epidemiol Community Health       Date:  2005-12       Impact factor: 3.710

4.  [Possible ways of managing cardiovascular prevention: polypharmacy, additional payment or application of evidence based medicine?].

Authors:  H Gohlke
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

5.  Population health: challenges for science and society.

Authors:  David Mechanic
Journal:  Milbank Q       Date:  2007-09       Impact factor: 4.911

6.  Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects.

Authors:  Paul Muntner; Devin Mann; Rachel P Wildman; Daichi Shimbo; Valentin Fuster; Mark Woodward
Journal:  Am Heart J       Date:  2011-04       Impact factor: 4.749

7.  Prediction of cardiovascular disease risk among low-income urban dwellers in metropolitan Kuala Lumpur, Malaysia.

Authors:  Tin Tin Su; Mohammadreza Amiri; Farizah Mohd Hairi; Nithiah Thangiah; Awang Bulgiba; Hazreen Abdul Majid
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

8.  Credential evidences of Ayurvedic cardio-vascular herbs.

Authors:  K Nishteswar
Journal:  Ayu       Date:  2014-04

9.  One pill, four questions: what we still need to know about reducing cardiovascular risk with combination therapy.

Authors:  Alun D Hughes
Journal:  Cochrane Database Syst Rev       Date:  2014-04-16

10.  Fixed drug combination in hypertension and hyperlipidaemia in the developing world.

Authors:  Y K Seedat
Journal:  Cardiovasc J Afr       Date:  2008 May-Jun       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.